NNC0113-5840 for Overweight or Obesity
A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- Age
- 18 – 55
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 48 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
This trial is looking for people who are overweight or have obesity to test a new medicine. Participants will either receive the new medicine NNC0113-5840 or a placebo that does not have any active ingredients.
You may be able to join if
- I am a male or female aged 18 to 55 years old.
- I have a body mass index (BMI) between 25.0 and 34.9.
- I have excess body weight due to fat, as judged by the doctor.
You may not be able to join if
- I have a known allergy to the study medicine or related products.
- I have a health condition that might make my participation unsafe.
- My HbA1c level is 6.5% or higher.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this clinical study is to find out if NNC0113-5840 is safe for treating people with excess body weight. There are 2 study treatments in this study, participants will get either NNC0113-5840 (the product being tested) or Placebo (treatment that has no active medicine in it), Which treatment participants get is decided by chance.
Loading trial locations…